News, Drug & Medical Device,

Christopher Seeger Appointed Co-Lead Counsel of Plaintiffs’ Steering Committee in Invokana MDL

On January 24, U.S. District Court Judge Brian R. Martinotti appointed Christopher A. Seeger to act as Co-Lead Counsel of the Plaintiffs’ Steering Committee in the Invokana multidistrict litigation (MDL).

Mr. Seeger had previously been serving as Interim Co-Liaison Counsel for Invokana cases in the District of New Jersey prior to the formation of the MDL. In that capacity, he successfully advocated on plaintiffs’ behalf and advanced the litigation through cooperative and constructive discussions with defense counsel.

Prior to his appointment in the Invokana matter, Mr. Seeger has served as court-appointed Co-Lead Counsel, Liaison Counsel, or member of Plaintiffs’ Committees in a wide array of complex and consequential multidistrict proceedings. This includes, recently, his appointment to the Plaintiffs’ Steering Committee in the Volkswagen “Clean Diesel” litigation; and his appointment as Co-Lead Class Counsel, representing retired players in litigation against the National Football League, in which he led negotiations that resulted in an uncapped settlement valued at approximately $1 billion.

Invokana is a medication manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and is used to treat Type 2 diabetes. The drug was approved by the FDA in March 2013. Since its release, the FDA has issued multiple safety warnings advising that people who use Invokana are at an increased risk for diabetic ketoacidosis, kidney failure, and amputation.  Additionally, FDA medical officers have raised concerns about the cardiovascular safety of the drug.

Receive our latest news updates on Twitter, Facebook and your inbox.